<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-21">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Giangrande</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Andreeva</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Chowdary</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A.</article-title>
  <source>
   <italic>Thromb Haemost.</italic>
  </source>
  <year>2017</year>;
  <volume>117</volume>(
  <issue>2</issue>):
  <fpage>252</fpage>â€“
  <lpage>61</lpage>. 
  <pub-id pub-id-type="doi">10.1160/th16-06-0444</pub-id>
  <?supplied-pmid 27904904?>
  <pub-id pub-id-type="pmid">27904904</pub-id>
 </mixed-citation>
 <note>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727073882" xmlns:xlink="http://www.w3.org/1999/xlink">F1000 Recommendation</ext-link>
  </p>
 </note>
</ref>
